Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States & United States — Medicare

27 shared events · Importance 5 · Last updated Sep 23, 2026

Importance
5
Shared Events
27
Actions
1
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
95
Regulatory
United States: The federal government is leading the crackdown, with CMS and DOJ actions affecting the healthcare system.
United States — Medicare: United States — Medicare is the primary program defrauded, with billions in fraudulent claims. The crackdown aims to protect its funds, but the fraud has eroded trust and increased scrutiny.
Aug 27, 2026 · 6 articles
82
Regulatory
United States: The United States government, through the Trump administration, is attempting to reduce healthcare costs for its citizens, particularly United States — Medicare patients.
United States — Medicare: United States — Medicare is the federal health insurance program whose patients are expected to save $1.1 billion annually due to the proposed rule, specifically those with United States — Medicare Part B coverage.
Jul 02, 2026 · 9 articles
71
Domestic
United States: The U.S. government, through the United States — White House, negotiated the drug pricing deals to lower costs for patients and reduce federal spending. The agreements are part of a broader push to make healthcare more affordable.
United States — Medicare: United States — Medicare is affected by the drug pricing negotiations and the new MFN deals, which aim to lower costs for beneficiaries. The administration's policies, including GLP-1 price reductions, may also impact United States — Medicare spending.
Aug 18, 2026 · 37 articles
69
Domestic
United States: The U.S. government was the victim of the fraud and facilitated the arrest through international cooperation.
United States — Medicare: Medicare was the victim of the alleged fraud, losing over half a billion dollars; the case highlights program vulnerabilities.
Jul 21, 2026 · 20 articles
67
Regulatory
United States: US authorities declared Mohammed a fugitive and seized nearly USD 6 million from accounts allegedly controlled by him, demonstrating federal enforcement action.
United States — Medicare: The federal healthcare program was defrauded of at least USD 65 million through false genetic testing claims, with roughly USD 13 million paid in a single 10-day period in 2023.
Sep 14, 2026 · 12 articles
52
Business
United States: The United States is another target market for LifeFit Group's expansion, representing a significant opportunity for growth.
United States — Medicare: United States — Medicare, the developer of LifeFit Group, leverages its healthcare expertise to enter the digital health space, potentially enhancing its brand and customer base.
Aug 11, 2026 · 8 articles
49
Business
United States: The United States is the primary market for Walmart, and its regulatory actions on United States — Medicare drug pricing negatively impacted Walmart's pharmacy sales. Weak retail sales data and consumer pessimism in the U.S. contribute to the challenging environment.
United States — Medicare: United States — Medicare regulations requiring capped prices on high-cost drugs reduced Walmart's pharmacy sales, contributing to the slower comparable sales growth. This regulatory impact is a key factor in the quarter's results.
Aug 20, 2026 · 7 articles
49
Domestic
United States: The United States>>> annually authorizes millions of dollars to support United States — United States Department of Veterans Affairs>>> clinicians in Veterans Treatment Courts and created a new center for this goal, but funding cuts still pose challenges.
United States — Medicare: Cuts to United States — Medicare>>>, a publicly funded healthcare program, are making it harder for veterans to access necessary healthcare services, impacting Veterans Treatment Courts.
May 19, 2026 · 6 articles
45
Tech
United States: The study was conducted in 27 sites across the United States, and its findings have significant implications for public health and healthcare spending within the nation.
United States — Medicare: Participants in the study were enrolled in United States — Medicare, and their claims data were linked, demonstrating the relevance of the study to public health insurance programs.
Jun 15, 2026 · 6 articles
45
Regulatory
United States: As the jurisdiction, the US legal system enforced anti-kickback laws, recovering funds and deterring future fraud.
United States — Medicare: Taxpayer-funded program affected by fraudulent billing; the scheme undermined its integrity and safeguards.
Aug 11, 2026 · 6 articles
45
Tech
United States: Setting of the study; potential public health implications for its aging population.
United States — Medicare: Provided claims data; central to the study's methodology.
Aug 25, 2026 · 7 articles
42
Regulatory
United States: The United States passed new PBM regulations in February, preventing PBMs from keeping rebates negotiated on drug prices for health plans supplementing federal United States — Medicare coverage. This indicates a federal-level intervention in PBM regulation.
United States — Medicare: United States — Medicare is affected by new federal regulations that prevent PBMs from keeping rebates on drug prices for health plans that supplement its coverage, aiming to lower costs for beneficiaries.
Jun 27, 2026 · 6 articles
39
Business
United States: The United States is the target market for Grey Matters Health Inc.'s expansion of neuroimaging clinics, addressing a growing demand for Alzheimer's detection and treatment within the country.
United States — Medicare: United States — Medicare covers brain PET scans for beta-amyloid plaque detection and new monoclonal antibody treatments for Alzheimer's Disease, which is crucial for patient access to Grey Matters Health Inc.'s services.
Jul 06, 2026 · 6 articles
34
Regulatory
United States: The regulatory decision and potential Medicare coverage affect the U.S. healthcare market and patients.
United States — Medicare: Legislation authorizes Medicare coverage of FDA-approved multi-cancer tests beginning in 2028, a key financial incentive for Grail.
Sep 23, 2026 · 18 articles
20
Business
United States: Its market accounts for the realized 9% U.S. price decline excluding rebates and is the base for the United States — Medicare GLP-1 Bridge Program expanding access.
United States — Medicare: Its GLP-1 Bridge Program granted 20 million eligible Americans coverage at $50 per month, a volume tailwind cited in the Lilly bull case.
Sep 14, 2026 · 6 articles
0
International
Jan 07, 2026 · 6 articles
0
Business
Jan 05, 2026 · 7 articles
0
Regulatory
Dec 18, 2025 · 15 articles
0
Regulatory
Dec 18, 2025 · 9 articles
0
Regulatory
Feb 18, 2026 · 7 articles
0
Business
Feb 24, 2026 · 13 articles
0
Domestic
Jan 01, 2026 · 10 articles
0
Domestic
Mar 19, 2026 · 7 articles
0
Regulatory
May 13, 2026 · 25 articles
0
Domestic
May 05, 2026 · 9 articles
0
Tech
United States — Medicare: Patients on United States — Medicare were more likely to discontinue GLP-1 medications, suggesting a demographic factor influencing adherence.
Jun 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States and United States — Medicare interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.